| Literature DB >> 22589289 |
Abstract
UNLABELLED: The Pseudomonas aeruginosa extracytoplasmic functioning (ECF) sigma factor σ(22) is encoded by algT/algU and is inhibited by anti-sigma factor MucA. σ(22) was originally discovered for its essential role in the expression of the exopolysaccharide alginate by mucoid strains associated with chronic pulmonary infection. However, σ(22) is now known to also have a large regulon associated with the response to cell wall stress. Our recent transcriptome analysis identified 293 open reading frames (ORFs) in the σ(22) stress stimulon that include genes for outer envelope biogenesis and remodeling, although most of the genes have undefined functions. To better understand the σ(22)-dependent stress response, mutants affected in 27 genes of the σ(22) stimulon were examined and expression was studied with lacZ fusions. Mutants constructed in the 27 genes showed no major change in response to cell wall-acting antibiotics or growth at elevated temperatures nor in alginate production. The mutants were examined for their effects on the expression of the σ(22)-dependent promoter of the alginate biosynthetic operon (PalgD) as a measure of σ(22) derepression from MucA. By testing PalgD expression under both planktonic and sessile growth conditions, 11 genes were found to play a role in the stress response that activates σ(22). Some mutations caused an increase or a decrease in the response to cell wall stress. Interestingly, mutations in 7 of the 11 genes caused constitutive PalgD expression under nonstressed conditions and thus showed that these genes are involved in maintaining envelope homeostasis. Mutations in PA0062 and PA1324 showed constitutive PalgD expression during both the planktonic and the sessile modes of growth. However, the PA5178 mutation caused constitutive PalgD expression only during planktonic growth. In contrast, mutations in PA2717, PA0567, PA3040, and PA0920 caused constitutive PalgD expression only in the sessile/biofilm mode of growth. This provides evidence that the σ(22) stimulon for cell envelope homeostasis overlaps with biofilm control mechanisms. IMPORTANCE: During chronic lung infections, such as in cystic fibrosis patients, Pseudomonas aeruginosa produces the exopolysaccharide alginate and forms biofilms that shield the organisms from the immune response and increase resistance to antibiotics. Activation of alginate genes is under the control of an extracytoplasmic stress response system that releases an alternative sigma factor (σ(22)) in response to cell wall stress and then activates expression of a large regulon. In this study, a mutant analysis of 27 members of the regulon showed that 11 play a role in envelope homeostasis and affect the stress response system itself. Interestingly, some genes demonstrate effects only in either the planktonic (free-swimming) or the sessile (biofilm) mode of growth, which leads to persistence and antibiotic tolerance. The studies presented here provide an important initial step in dissecting the mechanisms that regulate a critical signal transduction pathway that impacts P. aeruginosa pathogenesis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22589289 PMCID: PMC3372973 DOI: 10.1128/mBio.00094-12
Source DB: PubMed Journal: mBio Impact factor: 7.867
FIG 1 (A) Map of the algT/U operon. Arrows indicate promoters. (B) Model for the “activation” of σ22 activity by regulated intramembrane proteolytic (RIP) degradation of the anti-sigma factor MucA. Under nonstress conditions, σ22 activity is low due to its sequestration at the inner membrane by the MucA-MucB complex. In response to cell wall stress (e.g., d-cycloserine), AlgW cleaves MucA in the C terminus and then RseP (YaeL) and ClpXP cleave the MucA N-terminal region, releasing σ22 from posttranslational repression. This allows σ22 to complex with core RNA polymerase, thus increasing transcription of target promoters in the σ22 stimulon, which includes PalgD of the alginate biosynthetic operon. Abbreviations: OM, outer membrane; PG, peptidoglycan; IM, inner membrane.
Verification that selected genes were σ22 dependent by using a lacZ fusion analysis of each promoter in algT (σ22-deficient) and mucA (anti-sigma-factor-deficient) backgrounds
| Gene | Gene product description | Stress induction (15/60 min) | P- |
|---|---|---|---|
| PA0059 | OsmC, redox protein, osmotically induced | 9.9/8.9 | 156:15:450 |
| PA0062 | Hypothetical, predicted type II lipoprotein | 11.4/10.5 | ND |
| PA0460 | Hypothetical, predicted periplasmic | 18.9/7.7 | 1,569:116:5,161 |
| PA0567 | Proteolipid homolog, membrane integrity | 6.0/6.2 | 220:142:976 |
| PA0854 | FumC2, fumarate hydrase | 4.7/10.7 | ND |
| PA0919 | Hypothetical, predicted secretion usher | 3.0/<2 | Operon |
| PA0920 | Aminoacyl-phosphatidylglycerol synthase | 3.0/<2 | 3,264:2,825:5,239 |
| PA1243 | Predicted transcriptional regulator, PAS domain | 2.0/<2 | 87:30:307 |
| PA1323 | Hypothetical, DUF883 family | 19.8/15.9 | 269:13:1,278 |
| PA1324 | Predicted to bind/transport polysaccharides | 19.1/14.3 | Operon |
| PA2167 | Hypothetical, unclassified | <2/20.7 | 72:21:470 |
| PA2176 | Hypothetical, unclassified | <2/7.0 | 76:19:296 |
| PA2177 | Predicted sensor response hybrid, PAS domain | 2.2/<2 | 99:101:244 |
| PA2717 | Cpo, chloroperoxidase | <2/14.4 | ND |
| PA3040 | Hypothetical, DUF883 family | 7.1/6.2 | 1,352:1,073:4,148 |
| PA3459 | Predicted glutamine amidotransferase | 4.4/<2 | 402:415:839 |
| PA3691 | Hypothetical, predicted lipoprotein | 15.7/17.8 | 608:13:2,216 |
| PA3795 | Predicted oxidoreductase | 5.2/8.8 | 707:605:1,593 |
| PA3819 | SlyB homolog, outer membrane protein | 10.3/8.2 | 1,221:568:3,351 |
| PA4311 | Predicted glycosyltransferase | 4.0/6.9 | ND |
| PA4394 | Predicted mechanosensitive channel, McsS | 3.0/4.0 | 130:15:797 |
| PA4717 | Predicted periplasmic metalloprotease | 5.3/6.3 | 1,404:1,101:3,215 |
| PA5107 | Lipocalin Blc, outer membrane protein | 8.1/4.4 | Operon |
| PA5108 | Hypothetical, predicted lipoprotein | 7.5/3.0 | 714:387:3,732 |
| PA5178 | Hypothetical, LysM domain | 9.6/7.1 | 452:284:2,532 |
| PA5212 | Hypothetical, unclassified | 15.9/7.8 | 1,555:44:5,758 |
| PA5424 | Hypothetical, predicted inner membrane protein | 8.3/7.4 | 807:660:3,904 |
PAO1 gene names and descriptions were obtained from the Pseudomonas Genome Database (33) and are listed numerically. Sequence-defined transposon insertions in each gene were purchased from the University of Washington Genome Center. All were transduced into the PAO1/PDO1 reference isolate and verified by PCR analysis.
Stress induction shows data previously described (19) for the fold increase of the genes’ transcriptional activity expressed from the PAO1 chromosome when treated with d-cycloserine (400 µg/ml) for 15 or 60 min as determined by microarray analysis.
PAO1 (wild type [WT]), PDO-LS586 (algT), and PDO351 (mucA) strains containing each lacZ fusion plasmid were grown in L broth at 37°C with aeration, collected during logarithmic growth, and assayed for β-galactosidase activity. Data show each gene’s promoter activity (Miller units) when fused to lacZ (P-lacZ) when expressed in the wild type or in an algT or mucA mutant. “Operon” indicates that the gene is in an operon of a gene already tested. ND, not determined.
The mutant did not show the predicted σ22 stimulon phenotype until tested under cell wall stress conditions (see Table 2).
Confirmation of σ22-dependent gene expression during cell wall stress for selected promoters
| Promoter- | Fold increase in β-galactosidase activity due to | |
|---|---|---|
| PAO1 |
| |
| PA0567- | 2.3 | 10.9 |
| PA0920- | 5.6 | 2.6 |
| PA2177- | 14.2 | 2.3 |
| PA3040- | 10.0 | 2.2 |
| PA3459- | 9.0 | 2.4 |
| PA3795- | 11.4 | 3.3 |
| PA4717- | 8.8 | 2.8 |
| PA5424- | 19.2 | 1.7 |
Listed are promoter-lacZ fusions from Table 1 that did not yield the predicted phenotypes under unstressed conditions in algT and/or mucA mutant backgrounds. Here they were compared for β-galactosidase activity under cell wall stress conditions in PAO1 and an algT mutant by exposure to d-cycloserine. Bacteria were grown under routine lab conditions (L broth with aeration at 37°C) to an OD600 of 0.3 and treated with a sub-MIC level (400 µg/ml) of d-cycloserine for 60 min. The fold increase in β-galactosidase activity (Miller units) shown is a comparison to that of untreated control cultures. In PAO1 containing functional σ22, all 8 promoter fusions above showed an increase in transcriptional activity when exposed to d-cycloserine. None of these promoters, except PA0567-lacZ, showed high induction in the σ22 knockout, PAO1algT, indicating their dependence on σ22 for increased expression during cell wall stress.
FIG 2 Demonstration of a temperature-sensitive (Ts) growth phenotype. Mutants with Tn5-related (Tcr) insertions in genes of the σ22 stimulon were examined for growth defects compared to the parental strain, PAO1, in L broth at 45°C in a shaking water bath incubator. Among the 27 mutants examined, mutations in PA0062 or PA1324 caused a modest temperature-sensitive growth defect at 45°C. Shown is one of three experiments, all of which showed comparable results.
Comparison of PalgD induction in mutants of the σ22 stimulon when in the planktonic and sessile states of growth
| Phenotype | Strain/ | Activity | Sessile P | Putative role | |
|---|---|---|---|---|---|
| Wild type | PAO1 | 1:100 | Ring | ||
| Alterations in stressed | | | | | |
| PA5424 | 1:52 | Weaker ring | Membrane protein | ||
| PA1243 | 1:153 | Ring | Sensor/regulator | ||
| PA5107 | 1:134 | Ring | Lipocalin | ||
| Growth-independent alterations | | | | | |
| PA1324 | 1.7:151 (Ts) | Lawn | Polysaccharide binding | ||
| Planktonic growth-specific | PA5178 | 7:215 | Ring | LysM, BON domains | |
| Sessile growth-specific | | | | | |
| PA3040 | 1:100 | Lawn | DUF883 family | ||
| PA2717 | 1:142 | Lawn | Chloroperoxidase | ||
| PA0920 | 1:55 | Lawn | A-PG synthase |
PalgD-lacZ Miller units of β-galactosidase in PAO1 strains were 13 (±7) if untreated and 1,161 (±231) if treated with d-cycloserine. To be significant in the fold change, the ratio needed to be <0.5 or >1.5 for untreated cultures and <80 or >120 for treated cultures. When maximum activity was normalized to 100%, the untreated/treated ratio of PalgD-lacZ expression in PAO1 was typically 1:100. Ts indicates a temperature-sensitive growth defect at 45°C.
PalgD-cat activity in PAO1 strains was estimated on L agar plates containing chloramphenicol to prevent growth unless the cat fusion was activated by d-cycloserine placed in the center of the plate, which resulted in a ring of growth. In some mutants, a weaker ring of growth was observed. A lawn of growth indicated constitutive PalgD-lacZ expression under such sessile conditions.
A-PG, aminoacyl-phosphatidyl glycerol.
FIG 3 Sessile growth assay for observing the effects of mutations in genes of the σ22 stimulon on the activation of the σ22-dependent promoter, PalgD. Shown are pictures of plates of L agar plus chloramphenicol (Cm) coated with mutant derivatives of PAO1 that hosted pLW117, a plasmid containing PalgD-cat, which confers Cmr and thus growth when activated. A 5-mm filter disk impregnated with d-cycloserine was placed in the center of the plate. With PAO1, exposure to d-cycloserine (10 µg) in the center of the plate produced a ring of Cmr growth after 3 days at 25°C. A mucA mutant (devoid of the σ22 anti-sigma factor) is shown as an example of σ22 derepression. The other plates show a lawn of growth with the mutants indicated, which occurred with or without d-cycloserine and indicated constitutive activation of PalgD-cat due to the mutation.
FIG 4 Illustration of the roles of specific gene products in the σ22 stimulon on the “activation” of σ22 activity (i.e., by release from the MucA-MucB inhibitory complex). This was determined by examining the effect of mutations on envelope homeostasis, which leads to activation of PalgD. Mutations showed their effects when P. aeruginosa grew in the planktonic state of growth (left), the sessile/biofilm mode (right), or both (center).
P. aeruginosa strains and plasmids used in this study[
| Strain or plasmid | Genotype/phenotype | Source or reference |
|---|---|---|
|
| ||
| PAO1/PDO1 | Wild type, Cms | This laboratory |
| PDO-LS586 |
| 47 |
| PDO351 |
| 22 |
| PDO358 |
| 22 |
| PDO-PA0059 | PDO1, PA0059::Tn (Tcr) (transduced) | This study |
| PDO-PA0062 | PDO1, PA0062::Tn (Tcr) (transduced) | This study |
| PDO-PA0460 | PDO1, PA0460::Tn (Tcr) (transduced) | This study |
| PDO-PA0567 | PDO1, PA0567::Tn (Tcr) (transduced) | This study |
| PDO-PA0854 | PDO1, PA0854::Tn (Tcr) (transduced) | This study |
| PDO-PA0919 | PDO1, PA0919::Tn (Tcr) (transduced) | This study |
| PDO-PA0920 | PDO1, PA0920::Tn (Tcr) (transduced) | This study |
| PDO-PA1243 | PDO1, PA1243::Tn (Tcr) (transduced) | This study |
| PDO-PA1323 | PDO1, PA1323::Tn (Tcr) (transduced) | This study |
| PDO-PA1324 | PDO1, PA1324::Tn (Tcr) (transduced) | This study |
| PDO-PA2167 | PDO1, PA2167::Tn (Tcr) (transduced) | This study |
| PDO-PA2176 | PDO1, PA2176::Tn (Tcr) (transduced) | This study |
| PDO-PA2177 | PDO1, PA2177::Tn (Tcr) (transduced) | This study |
| PDO-PA2717 | PDO1, PA2717::Tn (Tcr) (transduced) | This study |
| PDO-PA3040 | PDO1, PA3040::Tn (Tcr) (transduced) | This study |
| PDO-PA3459 | PDO1, PA3459::Tn (Tcr) (transduced) | This study |
| PDO-PA3691 | PDO1, PA3691::Tn (Tcr) (transduced) | This study |
| PDO-PA3795 | PDO1, PA3795::Tn (Tcr) (transduced) | This study |
| PDO-PA3819 | PDO1, PA3819::Tn (Tcr) (transduced) | This study |
| PDO-PA4311 | PDO1, PA4311::Tn (Tcr) (transduced) | This study |
| PDO-PA4394 | PDO1, PA4394::Tn (Tcr) (transduced) | This study |
| PDO-PA4717 | PDO1, PA4717::Tn (Tcr) (transduced) | This study |
| PDO-PA5107 | PDO1, PA5107::Tn (Tcr) (transduced) | This study |
| PDO-PA5108 | PDO1, PA5108::Tn (Tcr) (transduced) | This study |
| PDO-PA5178 | PDO1, PA5178::Tn (Tcr) (transduced) | This study |
| PDO-PA5212 | PDO1, PA5212::Tn (Tcr) (transduced) | This study |
| PDO-PA5424 | PDO1, PA5424::Tn (Tcr) (transduced) | This study |
| Plasmids | ||
| pKK61 | pCP19 ( | 22 |
| pLW117 | pKK61 | This study |
| pLW127 | pSS269, PA0059 | 19 |
| pLW148 | pSS269, PA5178(−501/+50)- | This study |
| pLW149a | pSS269, PA3540 | 19 |
| pLW150 | pSS269, PA4394(−255/+60)- | This study |
| pLW152 | pSS269, PA3819(−660/+70)- | This study |
| pLW155 | pSS269, PA3691(−372/+59)- | 19 |
| pLW166 | pSS269, PA5108(−163/+70)- | 19 |
| pLW168 | pSS269, PA4717(−1130/+50)- | 19 |
| pLW179 | pSS269, PA1323(−450/+50)- | This study |
| pLW182 | pSS269, PA2176(−450/+50)- | This study |
| pLW183 | pSS269, PA2177(−450/+50)- | This study |
| pLW185 | pSS269, PA2167(−500/+50)- | This study |
| pLW186 | pSS269, PA0460(−500/+50)- | This study |
| pLW187 | pSS269, PA0567(−500/+50)- | This study |
| pLW188 | pSS269, PA0920(−500/+50)- | This study |
| pLW189 | pSS269, PA3040(−500/+50)- | This study |
| pLW190 | pSS269, PA3459(−500/+50)- | This study |
| pLW191 | pSS269, PA3795(−500/+50)- | This study |
| pLW194 | pSS269, PA5212(−500/+50)- | This study |
| pLW195 | pSS269, PA5424(−500/+50)- | This study |
| pRK2013 | ColE1-Tra(RK2)+ Kmr | 48 |
| pSS269 | pSS223 | 27 |
All P. aeruginosa strains were derived from PDO1, a spontaneous Cmr isolate of strain PAO1 previously described (28). Abbreviations: Gmr, aacCI-encoded gentamicin resistance; Apr, ampicillin/carbenicillin resistance; Kmr, kanamycin resistance; Alg+, mucoid due to alginate overproduction; lacZ, β-galactosidase reporter in transcriptional fusions; SF, stabilization fragment for replication in P. aeruginosa. Numbers in parentheses before lacZ indicate the promoter region in base pairs relative to the start of translation (+1) of the open reading frame used to make the transcriptional reporter.